Diclegis is a prescription medication that combines two active ingredients-doxylamine succinate and pyridoxine (vitamin B6)-in a single tablet. It belongs to the women’s-health therapeutic class and is formulated as a 10 mg/10 mg tablet. In Hong Kong, Diclegis is regulated by the Department of Health and is prescribed primarily for the management of nausea and vomiting during pregnancy (NVP).
Diclegis targets nausea through two complementary mechanisms:
Doxylamine succinate is an antihistamine that blocks H₁-histamine receptors in the brain. This action reduces the vestibular stimulation that can trigger the nausea reflex and also provides mild sedation that may improve sleep disrupted by morning sickness.
Pyridoxine (vitamin B6) participates in neurotransmitter synthesis, notably the conversion of tryptophan to serotonin. Adequate pyridoxine levels help normalize central pathways that regulate nausea and vomiting.
Together, the combination enhances the anti-nausea effect more reliably than either component alone, leading to better symptom control for many pregnant patients.
Diclegis is approved in Hong Kong for the treatment of nausea and vomiting of pregnancy, including mild to moderate cases that do not require hospitalization. The medication is intended for use throughout the first and second trimesters, when NVP is most common.
Key points for patients:
Some clinicians have explored the use of the doxylamine-pyridoxine combination for nausea related to chemotherapy or post-operative nausea, but these applications have not been approved by Hong Kong regulatory authorities. Limited case series suggest possible benefit, yet robust randomized trials are lacking.
Disclaimer: Off-label use requires close medical supervision, individualized risk assessment, and documentation of informed consent.
General Advice: Always disclose all medicines, supplements, and herbal products to the prescribing clinician before starting Diclegis.
Note: Dosing must be individualized; the above regimen reflects the typical prescribing information for Diclegis.
This article provides educational information about Diclegis and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Combining Diclegis with additional antihistamines (e.g., diphenhydramine) can increase sedation and impair alertness. If an extra antihistamine is needed, discuss dose adjustments with a clinician to avoid excessive drowsiness.
Air travel is generally safe, but the cabin environment may exacerbate fatigue. Carry the medication in your carry-on, stay hydrated, and avoid alcohol, which can heighten sedative effects.
Vitamin B6 alone may alleviate mild nausea, but the addition of doxylamine provides a stronger anti-nausea effect through histamine blockade. Clinical studies have shown the combination to be more effective for moderate NVP than vitamin B6 alone.
If sedation interferes with daily activities, consider taking the tablet at bedtime only, or discuss a lower initial dose with your provider. Do not increase the dose without professional advice.
In Hong Kong, Diclegis is marketed under a single brand name and tablet imprint. Generic versions, if available, may have distinct markings; always verify the imprint code with your pharmacist.
Extensive pregnancy safety data show no increased risk of major congenital anomalies when Diclegis is used as prescribed. It is classified as low-risk for teratogenicity.
Diclegis can be taken with or without food. Some patients find taking it with a light snack reduces stomach discomfort, but food does not significantly alter absorption.
The medication may be used throughout the first and second trimesters as needed. Discuss continuation into the third trimester with your obstetrician, as safety data beyond 28 weeks are limited.
Dispose of any remaining Diclegis tablets according to local pharmacy-take-back programs or follow the Hong Kong Department of Health’s instructions for safe medication disposal. Do not keep them for future pregnancies without consulting a clinician.
Small amounts of doxylamine and pyridoxine pass into breast milk, but studies suggest minimal impact on the infant. Nonetheless, mothers should monitor the infant for excessive sleepiness and discuss any concerns with a lactation specialist.